Press release
Mesenchymal Stem Cells Market to Exceed $10.21 B by 2033 on Regenerative Medicine Surge
Mesenchymal Stem Cells Market
Mesenchymal stem cells (MSCs) are a form of adult stem cells capable of differentiating into bone, cartilage, fat, and other tissues, with powerful applications in regenerative medicine, immunotherapy, and tissue repair. According to DataM Intelligence, the global MSC market was valued at approximately USD 3.45 Billion in 2024 and is projected to reach USD 10.21 Billion by 2033, reflecting a robust CAGR of 12.9%. This growth is fueled by increased funding, advanced manufacturing techniques, and expanding clinical success stories.
Get a Exclusive Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/mesenchymal-stem-cells-market?ophp
Mesenchymal Stem Cells Market Drivers
Based on DataM Intelligence insights, key drivers of the MSC market include:
• Rise in Regenerative Therapies: MSCs are being tested against conditions ranging from osteoarthritis and heart failure to immune disorders, as they exhibit both differentiation capacity and anti-inflammatory effects.
• Robust Clinical Pipeline: Dozens of phase II and III trials are underway globally, offering promise in conditions such as graft-versus-host disease and acute respiratory distress syndrome (ARDS).
• Technological Advancements: Innovations in cell processing-single-use bioreactors, cryopreservation, and potency assays-are improving scalability and reducing production costs.
• Regulatory Progress: Regulatory bodies like the FDA and Japan's PMDA are fine-tuning regulatory pathways, especially for autologous and allogeneic MSC treatments, providing clearer guidance to developers.
• Private and Public Funding: Sustained investment from government entities, venture capitalists, and big pharmaceutical companies is accelerating commercialization.
Mesenchymal Stem Cells Market Segments Overview
By Type(Allogeneic Mesenchymal Stem Cells, Autologous Mesenchymal Stem Cells) By Source (Bone Marrow, Adipose Tissue, Umbilical Cord, Dental Pulp, Placenta, Periosteum, Others) By Therapeutic Area(Cardiology, Neurology, Orthopedics, Oncology, Immunology, Others) By Application (Regenerative Medicine, Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others) By End-User (Hospitals, Specialty Clinics, Academic and Research Institutes, Others
Regional Outlook of Mesenchymal Stem Cells
North America
Holding over 45% of global MSC revenues, North America remains the market leader, driven by U.S. biotech firms, academic research hubs, and early reimbursement policies for MSC therapies, especially in orthopedics and immune conditions.
Europe
Europe is the second-largest market. The EU's Horizon Europe and Cure Europe Alliance support development of advanced therapy medicinal products (ATMPs), including MSC-based treatments, while France, Germany, and the UK lead in clinical trials.
Asia-Pacific
Asia-Pacific is the fastest-growing region. According to DataM Intelligence, countries like Japan, China, and South Korea have increased stem cell research funding. Japan's conditional approval system for regenerative therapies, like the Sakigake designation, has accelerated MSC-based cell therapy adoption.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/mesenchymal-stem-cells-market?ophp
Mesenchymal Stem Cells Market Players
Thermo Fisher Scientific Inc., Merck KGaA, Lonza Ltd, Bio-Techne, STEMCELL Technologies Inc., REPROCELL Inc., AcceGen, PromoCell GmbH, Celprogen Inc., and Cyagen Biosciences Inc., among others.
Emerging Players in Mesenchymal Stem Cells
The emerging players in the mesenchymal stem cells market include Mesoblast Ltd., Celltex Therapeutics, Beike Biotechnology, Athersys, Inc., and Cynata Therapeutics, among others.
Industry Momentum: Collaborations & Growth 2024-2025
• Mesoblast & Novartis Collaboration (January 2024): Co-development of MSC therapies for heart failure, combining clinical assets with commercial expertise from Novartis.
• BlueRock Therapeutics Acquisition (October 2024): Acquired an MSC-focused startup to enhance its pipeline in neuro-regenerative applications using induced pluripotent stem cell (iPSC) platforms.
• Fujifilm Cellular Dynamics & PL Bioscience Partnership (March 2025): Joint venture in Japan to scale MSC production for osteoarthritis treatment, leveraging Fujifilm's CGMP facilities.
• Vericel & Cella Therapeutics Merger (July 2024): Combined MSC R&D with autologous cell therapy tech to target cardiac repair post-myocardial infarction.
• Thermo Fisher & STEMCELL Technologies Alliance (May 2025): Co-developed single-use bioreactors and standardized assay kits to streamline MSC biomanufacturing.
Latest News from USA (2025)
In February 2025, the U.S. FDA granted Breakthrough Therapy designation to an allogeneic MSC therapy for moderate-to-severe Crohn's disease. Developed by a leading biotech, early-phase data showed significant remission rates with a favorable safety profile, positioning MSCs as a promising alternative for inflammatory bowel disease.
Latest News from Japan (2025)
In April 2025, Japan's PMDA issued conditional marketing approval for an MSC-based treatment targeting knee osteoarthritis, developed by a Tokyo biotech consortium. The therapy demonstrated improvements in cartilage health and pain scores in a 200-patient domestic trial. Prime Minister Saito emphasized Japan's regenerative medicine leadership
Directly purchase this exclusive report: https://www.datamintelligence.com/buy-now-page?report=mesenchymal-stem-cells-market?ophp
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mesenchymal Stem Cells Market to Exceed $10.21 B by 2033 on Regenerative Medicine Surge here
News-ID: 4078089 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Post-Bariatric Hypoglycemia Market to Surpass USD 341.83 million by 2031 Amid Ri …
Post-Bariatric Hypoglycemia Market Overview
Post-Bariatric Hypoglycemia (PPH), a condition marked by recurrent low blood sugar following weight-loss surgery, is increasingly recognized as a serious complication demanding medical attention. According to DataM Intelligence analysis, the global PPH market was valued at approximately USD 206.55 million in 2023 and is projected to reach USD 341.83 million by 2031, representing a compound annual growth rate (CAGR) of 6.5% during 2024-2031. This growth is propelled…
Left Ventricular Assist Devices (LVADs) Market to Surpass $2.67 Billion by 2033, …
Left Ventricular Assist Devices (LVADs) are mechanical circulatory support systems designed to assist the left ventricle in pumping blood in patients with advanced heart failure. Initially used as a bridge to transplantation, LVADs are now increasingly prescribed for long-term support. According to DataM Intelligence, the global LVAD market was valued at approximately USD 1.31 billion in 2024 and is projected to reach USD 2.67 billion by 2033, growing at a…
Hyper-Personalized Medicine Market to Hit USD 505.26 by 2033, Driven by AI Genom …
Hyper-personalized medicine delivers treatments tailored to an individual's unique genetic profile, lifestyle, and environment-far beyond traditional precision medicine. According to DataM Intelligence analysis, the global hyper-personalized medicine market was valued at approximately USD 256.72 billion in 2024 and is projected to reach USD 505.26 billion by 2033, growing at a robust compound annual growth rate (CAGR) of 7.9% during 2025-2033. Fueled by advances in genomics, AI-driven analytics, and digitized health…
Mobile Water Treatment Market to Grow at a CAGR of 7.2% During 2024-2031 on Risi …
Mobile Water Treatment Market Overview
Mobile water treatment systems are portable units that purify water on-site which is gaining traction in municipalities, industrial settings, military operations, and disaster relief scenarios. According to DataM Intelligence analysis, the global mobile water treatment market is demonstrating a strong compound annual growth rate (CAGR) of 7.2% during 2024-2031. This surge underscores the global need for reliable, transportable solutions to ensure safe water access during emergencies…
More Releases for MSC
Cruise Tourism Market Worth Observing Growth | Disney, MSC Cruises, NCL
A new business intelligence report released by HTF MI with title "Global Cruise Tourism Market Size, Status and Forecast 2018-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Cruise Tourism Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and…
Cruise Market is Booming Worldwide | Carnival , RCI , NCLH , MSC
HTF Market Intelligence released a new research report of 121 pages on title 'Global Cruise Market Report 2018' with detailed analysis, forecast and strategies. The study covers key regions that includes North America Country (United States, Canada) , South America , Asia Country (China, Japan, India, Korea) , Europe Country (Germany, UK, France, Italy) , Other Country (Middle East, Africa, GCC) and important players such as Carnival , RCI…
CAE Software Market | Key Players: Hexagon AB, MSC Software, Alatir
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of CAE Software market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. Some of the key players mentioned…
MSC Recognizes EAC Network at Breakfast of Champions
EAC Network received a Certificate of Appreciation from MSC at their second annual Breakfast of Champions event, which recognizes the Long Island company’s local nonprofit partners.
MSC is a leading North American distributor of maintenance, repair, and operations products and services based in Melville, NY. The company has built strong partnerships with local and national nonprofit organizations throughout its 75-year history.
MSC has supported EAC Network significantly through funding since…
FDM Honours First FDM MSc Programme Graduate
The UK’s leading IT graduate employer, FDM Group, has honoured its first graduate from the FDM MSc Programme at the Brighton Dome.
The graduation ceremony, held on 28th July, saw FDM Trainer Kevin Wright accept his Master’s in Applied Computer Science from University of Brighton. FDM fully-funded the course, which he studied via distance learning alongside his day job with the company.
Developed in partnership with University of Brighton,…
Info Session - MSc Program Engineering Management
Your key to the top engineeRing league!
On May 8, 2008 the info session for the MSc Program Engineering Management takes place at the Vienna University of Technology.
This part-time MSc Program is tailor-made for Europe`s small and medium-sized enterprises facing a growing and increasingly competitive market. It is design to prepare graduates from technical and economic universities for leadership roles in technical, corporate and national affairs.
The Academic Director Prof. DDr.…
